Journal profile · Materials Science-Biomaterials
Regenerative Biomaterials
ISSN 2056-3418 · eISSN 2056-3426 · Oxford University Press · United Kingdom
Regenerative Biomaterials: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.49; fully open access; APC about USD 1,820; median 92 days to acceptance (108 articles, last 24 months); 138 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Regenerative Biomaterials is published by Oxford University Press and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bone Tissue Engineering Materials, Electrospun Nanofibers in Biomedical Applications and Tissue Engineering and Regenerative Medicine, together about 33.5% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Regenerative Biomaterials is an international, interdisciplinary, peer-reviewed journal publishing the latest advances in biomaterials and regenerative medicine. The journal provides a forum for the publication of original research papers, reviews, clinical case reports, commentaries, and perspectives on the topics relevant to the development of advanced regenerative biomaterials concerning novel regenerative technologies and therapeutic approaches for the regeneration and repair of damaged tissues and organs. The interactions of biomaterials with cells and tissue, especially with stem cells, will be of particular focus. Reports on cells or stem cells in regenerative medicine but without materials will not be included. The journal will be a platform on biomaterials for communications among various disciplines involved with biomaterials, nanotechnologies, stem cell biology, regenerative medicine, and clinical medicine. The scope of Regenerative Biomaterials includes, but is not limited to: Design, synthesis, and evaluation of biomaterials for tissue engineering and regenerative medicine Design, evaluation and clinical use of biomaterials that contribute to tissue regeneration and regenerative processes Nanotechnologies and novel processing for preparation of biomimetic scaffolds Interaction of biomaterials with cells, especially stem cells Regenerative mechanisms of tissue by using biomaterials and/or stem cells Drug/gene delivery materials and methods Clinical applications of regenerative biomaterials Scientific base of evaluation and quality control of biomedical materials Surface modification methods of biomaterials and their effect on regenerative medicine Safety assessment of biomedical materials Stem cells fate controlled by materials signals Improvement of implanted medical devices Biomechanics of biomaterials and devices Regenerative engineering
From the journal's Aims & Scope
Research area (LetPub): Materials Science-Biomaterials
Editor-in-chief Nicholas PeppasPublisher website
Editorial board by country: 34 in mainland China (about 45%); most named Mainland China 34, United States 19, United Kingdom 4, Japan 2, South Korea 2 (75 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bone Tissue Engineering MaterialsEngineering16.7%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science9.7%
- Tissue Engineering and Regenerative MedicineMedicine7.2%
- Wound Healing and TreatmentsMedicine6.5%
- 3D Printing in Biomedical ResearchEngineering6.3%
- Nanoplatforms for cancer theranosticsEngineering5.8%
- Graphene and Nanomaterials ApplicationsEngineering4.5%
- Periodontal Regeneration and TreatmentsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Materials Science, Biomaterials | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Materials Science, Biomaterials | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Materials Science, Biomaterials | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexPMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.49LetPub ·
- Impact factor (publisher) 2025
- 11.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 8.1Publisher website ·
- CiteScore 2026-06
- 11.8LetPub ·
- CiteScore (publisher) 2025
- 11.8Publisher website ·
- SJR 2026-06
- 1.39LetPub ·
- SNIP 2026-06
- 1.07LetPub ·
- h-index
- 67OpenAlex ·
- i10-index
- 642OpenAlex ·
- 2-year mean citedness
- 7.74OpenAlex ·
- Self-citation rate
- 11.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 135LetPub ·
- Articles per year (publisher)
- 2,022Publisher website ·
Articles by year OpenAlex count · 1,077 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 212 | 212 | 98 |
| 2025 | 138 | 138 | 1,203 |
| 2024 | 150 | 150 | 2,570 |
| 2023 | 114 | 114 | 2,962 |
| 2022 | 112 | 112 | 3,780 |
| 2021 | 86 | 86 | 2,645 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
92 daysMedian, submission to acceptance · P25–P75 73 days – 112 days
- Acceptance to online
- median 13 days (108 articles)
- Submission to online
- median 106 days
- Sample
- 108 articles with submission and acceptance dates (330 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Peer review
- Peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,820 | — | — | |
| LetPub | USD 1,732 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Colour charges
- No colour charges
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Keywords
- 1–9
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Graphical abstract
- Required
Article types accepted5
- brief reportRegenerative Biomaterials welcomes the following main types of manuscripts that are subjected to peer review: Article type Abstract word count Abstract structur…Length not stated
- editorialRegenerative Biomaterials welcomes the following main types of manuscripts that are subjected to peer review: Article type Abstract word count Abstract structur…Length not stated
- perspectiveRegenerative Biomaterials welcomes the following main types of manuscripts that are subjected to peer review: Article type Abstract word count Abstract structur…Length not stated
- research articleRegenerative Biomaterials welcomes the following main types of manuscripts that are subjected to peer review: Article type Abstract word count Abstract structur…Length not stated
- reviewRegenerative Biomaterials welcomes the following main types of manuscripts that are subjected to peer review: Article type Abstract word count Abstract structur…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Self-archiving
- Authorship Authorship
Authorship is limited to those who have made a significant contribution to the design and execution of the work described. Any contributors whose participation does not meet the criteria for authorship should be acknowledged but not listed as an author. The Journal will contact all listed authors at the point of submission to confirm their role. For a detailed definition of authorship, please see …
Source ↗Publisher website ·- Conflicts of interest Disclosure of potential conflicts of interest
Authors The Journal requires all authors to disclose any potential conflict of interest at the point of submission. It is the responsibility of the corresponding author to ensure that conflicts of interest of all authors are declared to the Journal. A conflict of interest exists when the position, activities, or relationships of an individual, whether direct or indirect, financial or non-financial…
Source ↗Publisher website ·- Data availability Availability of data and materials
Where ethically feasible, the Journal strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. Whenever possible, data should be presented in the main manuscript or additional supporting files or deposited in a public repository. Visit our Research data page for information on general repositories for all data types, and resour…
Source ↗Publisher website ·- Publication ethics Screening for misconduct
Manuscripts may be screened using iThenticate to help detect publication misconduct including plagiarism and redundant publication. Manuscripts may also be screened, including with services provided by third parties, to help detect integrity issues such as inappropriate image alteration and papermill activity.
Source ↗Publisher website ·- License & copyright Open Government Licence
The Open Government Licence is an open licencing model for content produced by employees of UK Crown bodies allowing users to copy, publish, distribute, adapt and transmit the Information for commercial and non-commercial purposes. For additional information visit the gov.uk information on the Open Government Licence.
Source ↗Publisher website ·- Open access Open access charges
Please see the details of open access licences and charges. As the Journal is fully open access, you must pay the open access charge or request to use an institutional agreement to pay the open access charge through our licencing and payment portal, SciPris. Please note that prices are subject to change. All stated charges are exclusive of any applicable value added tax, goods and services tax and…
Source ↗Publisher website ·- Peer review Peer review process
The Journal uses the ANSI/NISO Standard Terminology for Peer Review. If you would like further description of the peer review terms used here, please refer to the most recent standard definitions. If further clarification is needed, please contact the editorial office at info2@csbm.org.cn. Peer review summary: Identity transparency: single anonymized Reviewer interacts with: editor Review informat…
Source ↗Publisher website ·- Preprints Preprints
As an author, you retain the right to make an Author’s Original Version (preprint) available through various channels and this does not prevent submission to the Journal. If accepted, you are required to update the status of any preprint, including adding your published paper’s DOI. For full details on allowed channels and updating your preprint, please see our Author self-archiving policy.
Source ↗Publisher website ·- Self-archiving Self-archiving
Self-archiving refers to posting a copy of your work on a publicly accessible website or repository. Under certain circumstances, you may self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories. For information about the Journal's policy, and to learn which version(s) of your paper are acceptable for self-archiving, please see our Author self-a…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2056-3418
- Electronic ISSN
- 2056-3426
- Society / sponsor
- Chinese Society for Biomaterials
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Regenerative Biomaterials
What CAS zone is Regenerative Biomaterials in?
In the 2025 upgraded edition of the CAS Journal Ranking, Regenerative Biomaterials is in Zone 2 of Medicine, and in Zone 2 of the minor category Materials Science, Biomaterials. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Regenerative Biomaterials?
The latest impact factor listed by LetPub is 8.49; CiteScore 11.8, h-index 67.
How long does peer review take at Regenerative Biomaterials?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 73–112 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Regenerative Biomaterials?
According to the journal's author guidelines: Keywords: 1–9; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Regenerative Biomaterials based?
Of the 75 board members whose country the journal's board page names, 34 (about 45%) are in mainland China; the countries named most often are Mainland China (34), United States (19) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Regenerative Biomaterials?
According to LetPub and DOAJ records, Regenerative Biomaterials is indexed in SCIE, Scopus and DOAJ. The journal's website also lists EI Compendex and PMC; that list has not been checked against each database.
Is Regenerative Biomaterials open access, and what is the APC?
Regenerative Biomaterials is a fully open-access journal. APC about USD 1,820.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .